<HashMap><database>ecrin-mdr-crc</database><scores/><additional><omics_type>Clinical</omics_type><study_start_year>2008</study_start_year><condition>Chronic non-cancer pain and bowel function</condition><disease>Chronic Non-cancer Pain And Bowel Function</disease><study_type>Interventional</study_type><full_dataset_link>https://newmdr.ecrin.org/Study/2423319</full_dataset_link><location>Canada</location><study_start_month>7</study_start_month><keyword>Study drug 038</keyword><keyword>controlled-release oxycodone HCl</keyword><repository>ECRIN MDR</repository><study_status>Completed</study_status></additional><is_claimable>false</is_claimable><name>A randomised, crossover study of study drug 038 and controlled-release oxycodone HCl tablets in patients with chronic non-cancer pain</name><description>Study hypothesis: Study drug 038 will be superior to controlled-release (CR) oxycodone on bowel function and not inferior to CR oxycodone in pain control in patients with chronic non-cancer pain.
As of 13/08/2010 this record was updated to include an extended end date; the initial anticipated end date at the time of registration was 15/09/2009. 
As of 10/01/2011 this record was again updated to include an extended end date; the previous anticipated end date at the time of registration was 31/03/2011.
Primary outcome(s): Pain intensity and bowel function measured during the last week of treatment in each phase.</description><dates><creation>2008-07-15</creation></dates><accession>2423319</accession><cross_references><ISRCTN>ISRCTN76170309</ISRCTN></cross_references></HashMap>